Home » News » Awards & Advancement » Colleen Goggins joins QuintilesIMS Board of Directors

Colleen Goggins joins QuintilesIMS Board of Directors

Thursday, July 27, 2017

QuintilesIMS, a provider of information, technology solutions and contract research services to the life sciences industry, announced the appointment of Colleen Goggins to its board of directors, effective today. A senior executive at Johnson & Johnson for more than three decades, Goggins retired in 2011 after serving ten years on J&J’s Executive Committee and as the Worldwide Chairman of its Consumer Group. Under her leadership, the J&J global personal and healthcare portfolio, comprising many of the most recognized consumer brands and medicines in the world, grew to more than $16 billion in annual revenue.

“We are delighted that Colleen has accepted to join our board,” said Ari Bousbib, QuintilesIMS chairman and CEO. “She brings broad life sciences experience, a proven commitment toward improving public health and demonstrated leadership in developing and commercializing an array of therapies.”

Goggins is a member of the supervisory board of Bayer AG and a member of the board of directors of TD Bank Group. Goggins is also a member of the University of Wisconsin Foundation and serves on the boards of directors of the University of Wisconsin Center for Brand and Product Management, the Child Health Institute of New Jersey, the Institute of International Education, and New York City Meals-on-Wheels.

Related Posts